LatchBio
PrivateLast Round
Series B
Apr 1, 2026
Est. Valuation
$500M
Total Funding Raised
$33M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
LatchBio operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A round in June 2022.
LatchBio is a biotechnology company that provides a cloud-based, no-code bioinformatics platform designed to help researchers store, analyze, and visualize biological data.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Cloud Infrastructure, Data Integration
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LatchBio Comparables
Compare LatchBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DNAnexus | 84% | |
| Seqera | 81% | |
| Elucidata | 79% |
For institutional investors. Book with your work email.
LatchBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 1, 2026 | ||||
| Series A | Jun 2, 2022 | ||||
| Seed | Oct 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
LatchBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Haystack | Seed, Series A |
| Lux Capital | Seed, Series A |
| General Catalyst | Seed |
| Caffeinated Capital | Series A |
| Fifty Years | Seed, Series A |
| Coatue Management | Series A |
| Hummingbird Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 25, 2026
Grew 78% QoQ, from 41 to 73 employees.
- Sep 11, 2026
Monthly visitors grew 32% MoM, reaching 38.7K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 28, 2026
Latch Bio, Inc. partners with Fireworks AI, Inc. to add BioBench, its suite of evaluations on benchmarks.bio, to the Specialized Intelligence Index on Oct 28th '26.
- launchesOct 19, 2026
Latch Bio, Inc. adds live monitoring of model trajectories to ensure alignment between tool calls and model behavior.
- launchesSep 29, 2026
On Sep 29th '26, Latch Bio, Inc. introduces MetagenomicsBench, a verifiable benchmark designed to test whether AI agents can make decisions across real-world metagenomic analyses.
- launchesSep 2, 2026
Latch Bio, Inc. introduces the Antibody Discovery Benchmark, an experimentally grounded benchmark that tests whether AI agents make scientific decisions across therapeutic antibody discovery, on Sep 2nd '26.
For institutional investors. Book with your work email.
LatchBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about LatchBio's valuation, stock price, and market status.
Is LatchBio a public or private company?
LatchBio is a private company.
What is the current stock price of LatchBio?
LatchBio is a private company, so its shares have no public market price. Caplight tracks LatchBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LatchBio worth (valuation)?
LatchBio's valuation is estimated at $500.0M based on funding round data.
Can I buy LatchBio stock?
LatchBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LatchBio's last funding round?
LatchBio's most recent funding round was Series B on April 1, 2026.
Who are the main investors in LatchBio?
Key investors in LatchBio include Lux Capital, Coatue Management.
Will LatchBio IPO soon?
No public IPO plans have been announced for LatchBio.
How can I track LatchBio secondary market activity?
Caplight tracks bids, offers, and trades in LatchBio's shares on secondary markets.